BELLINI trial

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

BELLINI trial

Sep 27, 2024, 16:31 | Insight

Immunotherapy for aggressive breast cancer appears to be effective even without chemotherapy - The Netherlands Cancer Institute

The Netherlands Cancer Institute posted on LinkedIn: "Immunotherapy as a treatment for an aggressive form of…

Sep 20, 2024, 08:16 | Blog

Yakup Ergün: Nivolumab/Relatlimab or Nivolumab/Ipilimumab in TNBC

Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Neoadjuvant nivolumab/relatlimab or nivolumab/ipilimumab in…

Apr 18, 2024, 13:58 | Insight

Ben Derman: Should MRD negativity be accepted as a surrogate endpoint for clinical trials in myeloma

Ben Derman, Assistant Professor at the University of Chicago, shared on X/Twitter: "Should MRD negativity…

All: 3 Posts: 1 - 100

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

'

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

'

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023